Vaishali Pharma Limited (NSE:VAISHALI)

Vaishali Pharma Revenue

In the fiscal year ending March 31, 2026, Vaishali Pharma had annual revenue of 1.13B INR with 13.72% growth. Vaishali Pharma had revenue of 281.89M in the quarter ending March 31, 2026, a decrease of -12.58%.

• Revenue: 1.13B
• Revenue Growth: +13.72%
• P/S Ratio: 0.83
• Revenue / Employee: 41.71M
• Employees: 27
• Market Cap: 931.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.13B	135.82M	13.72%
Mar 31, 2025	990.26M	127.46M	14.77%
Mar 31, 2024	862.80M	166.17M	23.85%
Mar 31, 2023	696.63M	-61.58M	-8.12%
Mar 31, 2022	758.21M	220.47M	41.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error